Accessibility Menu
McKesson logo

McKesson(NYSE) MCK

Market Cap$100.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1994)+6,788%
5 Year+342%
1 Year+28%
1 Month+2%
$861.72
-0.84%
-7.28Today
Pre market$862.57+$0.85 (+0.10%)
McKesson last closing stock price
MetricPriceDate
Last closeUSD 859.922026-08-17
McKesson stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.27%USD 879.872026-08-10
1 month+2.2%USD 841.392026-07-17
3 month+12.99%USD 761.052026-05-19
Year to date+5.03%USD 818.702025-12-31
1 year+28.28%USD 670.322025-08-15
3 year+107.35%USD 414.722023-08-18
5 year+342.37%USD 194.392021-08-18
Since inception+6,788.1%USD 12.481994-11-10

McKesson Financials at a Glance

Market Cap

$100.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$410.98B

Net Income (TTM)

$4.59B

EPS (TTM)

$37.37

P/E Ratio

23.01

Dividend

$3.28

Beta (Volatility)

0.22 (Low)

Price

$861.72

Volume

219.31

Open

$859.49

Previous Close

$859.92

Daily Range

$855.93 - $879.34

52-Week Range

$667.50 - $999.00

Estimated Earnings Date

Nov 4, 2026

MCK News

A magnifying glass held over a sheet detailing company finances.

What Is the Fortune 100?

Matt DiLalloNov 19, 2025
Man presenting data to colleagues

What Is the Fortune 500?

Kristi WaterworthOct 12, 2025
Child receiving a vaccination shot from a healthcare professional

Why McKesson Stock Bumped Modestly Higher Today

Eric VolkmanMay 9, 2025
Hospital-healthcare-nurse-patient.jpg

McKesson Exceeds EPS, Q3 Profit Surges

Motley Fool Markets TeamFeb 5, 2025
GettyImages-928320744-600x372-132bd13.jpg

McKesson's Fiscal Q2 EPS Tops Forecast

Motley Fool Markets TeamNov 6, 2024
GettyImages-1342134425.jpg

McKesson: EPS Soars, Revenue Misses

Motley Fool Markets TeamAug 7, 2024
medical staff talk with management

This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks

Alex CarchidiDec 4, 2023
surgical gloves and surgical lights in the operating room

2 Best Buffett Stocks to Buy for the Long Haul

James HalleyJun 26, 2023
Page 1

MCK: Motley Fool Moneyball Superscore

78

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About McKesson

McKesson Corporation helps people get essential medicines and health supplies. It delivers drugs and tools to doctors, hospitals, and neighborhood pharmacies. These services make quality healthcare more accessible for patients everywhere.

Moving Medicines and Health Supplies

  • North American Pharmaceutical: Distribution and logistics services for branded, generic, and specialty drugs to pharmacies and hospitals.
  • Oncology and Multispecialty: Specialty drug delivery and business support for a large network of community-based cancer care clinics.
  • Prescription Technology: Software and automated tools that help patients access and afford their prescribed medications.
  • Medical-Surgical Solutions: Logistics and supply chain services for medical equipment used in clinics and home healthcare settings.

Strategic Shifts and Acquisitions

  • Sold a 13% stake in the medical-surgical business to Apollo Global Management for $1.25 billion in June 2026.
  • Acquired interests in Core Ventures for $2.5 billion and PRISM Vision for $874 million in 2025.
  • Approved an initiative in April 2026 to increase operational efficiency within the prescription technology segment.
  • Planned the separation of the medical-surgical solutions business into a new, independent company.

Specialized Networks and Technology

McKesson manages one of the largest networks of integrated, physician-led oncology practices in the United States. Its technology platforms connect pharmacies and biopharmaceutical companies to solve medication access and adherence challenges.

Performance by the Numbers

  • Revenue was $105.4 billion for the three months ended June 30, 2026, up 8% year over year.
  • Net income hit $614 million in the first quarter of fiscal 2027, down 22% year over year.
  • North American Pharmaceutical revenue reached $86.8 billion for the three months ended June 30, 2026.
  • Cash returned to shareholders reached $2.6 billion during the three months ended June 30, 2026.
  • Estimated litigation liability for opioid-related claims totaled $5.7 billion as of June 30, 2026.

Bottom Line

McKesson has shifted toward high-growth specialty care and technology solutions for the healthcare industry. The company is currently streamlining its business by planning to spin off its medical-surgical supply unit.

AI Generated • Aug 6, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

43,000

CEO

Brian Scott Tyler, PhD

Website

www.mckesson.com

Headquarters

Irving, TX 75039, US

MCK Financials

Key Financial Metrics (TTM)

Gross Margin

3.64%

Operating Margin

1.62%

Net Income Margin

1.12%

Return on Equity

-194.39%

Return on Capital

100.19%

Return on Assets

5.20%

Earnings Yield

4.35%

Dividend Yield

0.38%

Payout Ratio

8.56%

Stock Overview

Market Cap

$100.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

116.59M

Volume

219.31

Avg. Volume

1.12M

Financials (TTM)

Gross Profit

$14.96B

Operating Income

$6.65B

EBITDA

$7.15B

Operating Cash Flow

$6.85B

Capital Expenditure

-$220.00M

Free Cash Flow

$6.63B

Cash & ST Invst.

$5.16B

Total Debt

$11.70B

McKesson Performance Analysis

McKesson annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 276,711,000,0004.8%
20242024-03-31USD 308,951,000,00011.7%
20252025-03-31USD 359,051,000,00016.2%
20262026-03-31USD 403,430,000,00012.4%
McKesson sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-305.4%
Q32025-12-312.9%
Q42026-03-31-9.3%
Q12026-06-309.4%
McKesson annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD 25.04246.3%
20242024-03-31USD 22.39-10.6%
20252025-03-31USD 25.7214.9%
20262026-03-31USD 38.3749.2%
McKesson sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3042.7%
Q32025-12-317.5%
Q42026-03-3143.0%
Q12026-06-30-62.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

$105.38B

+7.7%

Gross Profit

$3.69B

+12.4%

Gross Margin

3.50%

N/A

Market Cap

$100.26BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.37M

N/A

Employees

42,300

N/A

Net Income

$614.00M

-21.7%

EBITDA

$1.39B

+10.2%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

$5.16B

+113.6%

Total Debt

$11.70B

+17.8%

Accounts Receivable

$30.32B

+7.7%

Inventory

$26.26B

+4.8%

Long Term Debt

$10.11B

+20.6%

Short Term Debt

$1.59B

+2.8%

Return on Assets

5.20%

N/A

Return on Invested Capital

37.02%

N/A

Free Cash Flow

-$332.00M

+67.7%

Operating Cash Flow

-$220.00M

+76.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GSKGSK plc
$50.28+1.53%
SNYSanofi
$44.41+1.58%
HCAHCA Healthcare, Inc.
$404.98+0.07%
MDTMedtronic plc
$90.60-0.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$38.36-0.05%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$151.53+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$76.40-0.01%
NOKNokia
$10.78+0.00%

Questions About MCK

What is the current price of McKesson?

McKesson is trading at $859.92 per share.

What is the 52-week range for McKesson?

Over the past 52 weeks, McKesson has traded between $667.50 and $999.00.

How much debt does McKesson have?

As of the most recent reporting period, McKesson reported total debt of $11.70B.

How much cash does McKesson have on hand?

McKesson reported $5.26B in cash and cash equivalents in its most recent financial results.

What is McKesson’s dividend yield?

McKesson currently has a dividend yield of 0.38%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services